EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS

EFFICACY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: to study the clinical efficacy, immunogenicity, and safety of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis (RA). Subjects and methods. The investigation enrolled 70 patients (55 women and 15 men) aged 23–70 years, including 40 patients with RA and 30 people witho...

Full description

Saved in:
Bibliographic Details
Main Authors: M. S. Naumtseva, B. S. Belov, G. M. Tarasova, D. E. Karateev, E. L. Luchikhina, Yu. V. Muravyev, E. N. Aleksandrova, A. A. Novikov
Format: Article
Language:Russian
Published: ABV-press 2015-05-01
Series:Klinicist
Subjects:
rheumatoid arthritis
autoimmune diseases
comorbid infections
comorbidity
pneumonia
bronchitis
pneumococcal vaccine
vaccination
immunogenicity
efficacy
tolerability
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/184
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://klinitsist.abvpress.ru/Klin/article/view/184

Similar Items